Active Ingredient
(in each captab)
Calcium polycarbophil 625 mg
The following Structured Product Label (SPL) was submitted to the FDA by Rugby Laboratories for the product Fiber Lax (NDC 0536-4306). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each captab)
Calcium polycarbophil 625 mg
Bulk-Forming Laxative
(equivalent to polycarbophil 500 mg)
Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.
longer than one week
taking any other drug. Take Fiber-Lax two or more hours before or after other drugs. Laxatives may affect how other drugs work.
These may indicate a serious condition.
In case of overdose, get medical help or contact a Poison Control Center right away.
Caramel, crospovidone, hypromellose, magnesium silicate, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, silica, sodium lauryl sulfate and stearic acid
Questions or comments?
Call 1-800-645-2158, 9 am - 5 pm ET, Monday – Friday
TAMPER EVIDENT: DO NOT USE IF BLISTER SEAL IS BROKEN OR DAMAGED
*Rugby Laboratories, Inc. is not affiliated with the owner of the trademark FiberCon®.
Fiber-Lax is distributed by Rugby Laboratories, Inc.
Rugby®
Duluth, Georgia 30097
www. Rugbylaboratories.com
* Please review the disclaimer below.